Browse Source

Add 1p-10-ProjectAIUR.md

dimpata 3 years ago
parent
commit
60edd178dc
2 changed files with 42 additions and 20 deletions
  1. 0
    20
      09-iGive2.md
  2. 42
    0
      1p-10-ProjectAIUR.md

+ 0
- 20
09-iGive2.md View File

@@ -1,20 +0,0 @@
1
-
2
-# iGive2
3
-
4
-iGive2 - Decentralizing chronic disease management with a community based human centred platform that motivates healthy living & self-care and helps to advance research
5
-
6
-PROJECT LEAD: Flavia Wahl TEAM COMPOSITION: iBreve & UniversalDoctor WEBSITE: http://igive2.mystrikingly.com PROJECT SECTOR: [“Health”]
7
-
8
-CORE TECHNOLOGIES: [“Distributed ledger technologies”,“Peer to peer technologies”,“Artificial intelligence”,“Internet of things”,“Immersive Media”]
9
-
10
-PROJECT BRIEF DESCRIPTION Chronic diseases are the leading cause of death globally, despite upto a staggering 80% of cases in some disease areas like hypertension can be prevented by behavioral & lifestyle choices. Chronic diseases must be managed 24 hours a day, 7 days a week, 365 days a year. Community care is a more logical approach for chronic disease management because it allows for more continuous care, rather than episodic interventions that only occur when a patient visits their formal care provider. iGive2 is an open & decentralized health care platform to help better manage and prevent chronic diseases by bringing together patients, their families and local communities. It empowers patients to have an impact in health care, which historically was exclusively managed by overloaded centralized institutions. At the same time iGive2 advances cross country chronic disease research in Europe. Clinicians & researchers face high hurdles to access large scale real world data to advance their research and the development of new therapies. The development of new prevention programs & therapies is often hindered by the lack of access to privacy conform aggregated real world data, needed to monitor their effectiveness. iGive2 provides researchers with a secure & GDPR conform platform that enables them to integrate and monitor biosensors & devices in their research studies.
11
-
12
-BUSINESS MARKET iGive2’s open research platform advances research in chronic diseases and at the same time improves the quality of life of patients. According to the World Health Organization, every Euro invested in prevention & tackling non-communicable diseases have a 7 fold return on investment for the society. The development of innovative wearable technologies has raised great interest in new means of data collection in healthcare and biopharmaceutical research and development. Multiple applications for wearables have been identified in a number of therapeutic areas; however, researchers face many challenges in the clinic, including scientific methodology as well as regulatory, legal, and operational hurdles. Adopting new ways of remote data collection can bring new treatments and care management to all patients in need. The global real-world evidence market is valued at 612M € in 2017 and projected to reach 1,348M € by 2023, at a CAGR of 14.3%. The growth of this market is majorly driven by the rising elderly population and the subsequent increase in the prevalence of chronic diseases.
13
-
14
-BUSINESS MODEL iGive2’s business model is built on 3 pillars: 1) Citizen can use it for free to monitor their health & build support hubs. They also have the choice to participate in research projects & donate or get reimbursed in exchange for their anonymized data. 2) Researcher can onboard their study participants on a customised iGive2 platform to get GDPR compliant access to real-time monitoring data with the wearables of their choice. 3) Cities, local shops or healthy living brands can join the platform with a donation type fee to offer sponsored reward campaigns that incentivize healthy behaviors
15
-
16
-TEAM EXPERIENCE We are a diverse and multidisciplinary team combining entrepreneurial expertise with digital health, software development & human centred design. The iGive2 team is supported by a GP that also advises the World Health Organization in health and innovation projects, team members that worked for renown innovative companies like IBM & Google and 1st class experience in entrepreneurship with team members that received multiple innovation awards like Ireland’s Best Young Entrepreneur.
17
-
18
-FUNDING NEEDS The ledger support enables us to build & test the MVP including the core components of the community & research platform. The projects seeks a seed round of €760,000 to create a secure & human centred platform that enables people to lead happier & healthier lives.
19
-
20
-STRATEGY AND SCALABILITY iGive2 aims to advance the UN Sustainable Development Goals by providing affordable access to healthcare and reducing poverty & inequality. In particular, to reduce premature mortality from chronic diseases by ⅓ through prevention & treatment and promote mental health & well being by 2030 (Target 3.4).

+ 42
- 0
1p-10-ProjectAIUR.md View File

@@ -0,0 +1,42 @@
1
+## 10 Project Aiur
2
+
3
+A knowledge validation engine combining blockchain and AI technology
4
+
5
+COMPANY NAME: Iris AI AS 
6
+APPLICANT NAME: Jacobo Elosua
7
+TEAM COMPOSITION: People from one or two legal entities
8
+WEBSITE: https://projectaiur.com/ 
9
+COUNTRY: Bulgaria
10
+USER: jet
11
+PROJECT SECTOR: ["Open Innovation"]
12
+
13
+### CORE TECHNOLOGIES: 
14
+["Blockchain technologies","Distributed ledger technologies","Peer to peer technologies","Artificial intelligence"]
15
+
16
+
17
+### PROJECT BRIEF DESCRIPTION
18
+
19
+We envision a world where the right scientific knowledge is available at our fingertips. Where all research is validated and reproducible, with immutable scientific consensus tracked over time. Where interdisciplinary connections are the norm. Where unbiased scientific information flows freely. Where research already paid for with our tax money is freely accessible to all. Where massive R&D budgets also benefit contributors to core scientific breakthroughs.
20
+
21
+### BUSINESS MARKET
22
+
23
+Our research assistance premium software products currently cater for university library and research institute use cases. From that toe in the water, our commercial efforts are expanding into corporate R&D, with chemistry as the initial (highly attractive but currently underserved) beachhead market. We believe the proposed Knowledge Validation engine presents an opportunity around R&D automation, a $14bn yearly revenue opportunity (11m R&D researchers and $138bn spent on digital enablers).
24
+
25
+### BUSINESS MODEL
26
+
27
+The token economics proposed display an ecosystem of different profiles of Contributors and Users incentivised to drive the Knowledge Validation Engine forward. Essentially, from a business model perspective we plan to create a circular token economy. Contributors generate tokens via the provision of value added activities to the Aiur system (training, code commits, research publishing, QA). Users will include R&D personnel, academic consortia, software developers and individual researchers.
28
+
29
+### TEAM EXPERIENCE
30
+
31
+Iris.ai is a seed funded, Singularity University, 500 Startups, Founders Factory, German Technology Entrepreneurship Centre and Creative Destruction Lab backed, three year old international startup developing an AI to democratize access to scientific knowledge.
32
+Since founding Iris.ai in 2015 we have focused our efforts on developing a machine that can read and understand scientific text. Our initial trajectory has been covered by Fast Company, TechCrunch, Wired, Science Magazine or the World Economic Forum, among others.
33
+
34
+### FUNDING NEEDS
35
+
36
+Used as a lever, pooled with other investor money to make the project a reality.
37
+
38
+### STRATEGY AND SCALABILITY
39
+
40
+We have fundamentally modelled the AIUR token as: (1) the sole instrument available for the community to tap into Aiur directly via an Application Programming Interface (’API’); and, at the same time, (2) a potential voucher, i.e. a digital right to purchase products built on top of Aiur at a discount.
41
+Our primary goal distributing AIUR tokens is to align long term incentives with a large and fast growing base of existing community members and early backers, acting as individuals, corporates or institutions. Our secondary goal is to maximize breadth of holders, in particularly among target Aiur users.
42
+Besides rewarding existing relationships, the project’s marketing efforts will target allocating tokens in advantageous terms to early backers, and in particular both existing and aspiring scientists, via mechanisms including airdrop and/or bounty campaigns. The Aiur token sale will also target maximizing breadth of holders through expansive social media communications.